Replies to post #693163 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

At a minimum we know as a hard fact that an efficacy IA was performed prior to the endpoitnt change.

The FDA says that changing the endponts based on information from the trial is a big no-no. And the results of an IA is huge wrt the likelyhood f the initial endpoints failing.